abstract |
The present invention relates to the field of production of natural killer (NK) cells genetically modified with lentiviral vectors carrying polynucleotides encoding chimeric antigen receptor (CAR). The present invention further relates to CAR-NK cells obtained by the method and, in particular, to the use of CAR-NK cells in medicine for use in a method of treating cancer. |